Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.

Authors:
Vincenzo Bruzzese
Vincenzo Bruzzese
"Nuovo Regina Margherita" Hospital
Italy

J Clin Rheumatol 2012 Dec;18(8):413-5

Internal Medicine and Rheumatology Unit, Nuovo Regina Margherita Hospital, Rome, Italy.

We report the case of a patient with a simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis. This condition differs from both the PASH (pyoderma gangrenosum, acne, and suppurative hidradenitis) syndrome, in which arthritis is absent, and the PAPA (pyogenic arthritis, pyoderma gangrenosum, and acne) syndrome, in which suppurative hidradenitis is lacking. Our patient failed to respond to etanercept therapy, whereas all dermatologic and rheumatic manifestations completely regressed following infliximab infusion. We therefore propose that simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and seronegative spondyloarthritis might represent a distinct syndrome that could be termed the PASS syndrome. Tumor necrosis factor α therapies seem to play selective roles.

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0b013e318278b84cDOI Listing
December 2012
8 Reads

Publication Analysis

Top Keywords

gangrenosum acne
20
suppurative hidradenitis
20
pyoderma gangrenosum
20
conglobata suppurative
12
acne conglobata
12
axial spondyloarthritis
8
presence pyoderma
8
simultaneous presence
8
hidradenitis axial
8
necrosis factor
8
suppurative
5
acne
5
hidradenitis
5
pyoderma
5
etanercept therapy
4
therapy dermatologic
4
respond etanercept
4
rheumatic manifestations
4
manifestations completely
4
dermatologic rheumatic
4

Similar Publications

Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?

Australas J Dermatol 2017 May 2;58(2):e54-e59. Epub 2016 Feb 2.

Clinic of Dermatovenereology, Clinical Centre of Serbia, Belgrade, Serbia.

The clinical triad of pyoderma gangrenosum, acne conglobata and hidradenitis suppurativa has been named PASH syndrome. Polycystic ovary syndrome (PCOS) is associated with hyperandrogenism and inflammation. Hidradenitis suppurativa, like acne vulgaris, may be a feature of hyperandrogenism. Read More

View Article
May 2017

Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome.

J Am Acad Dermatol 2012 Mar 13;66(3):409-15. Epub 2011 Jul 13.

Department of Dermatology and Allergy, Ludwig-Maximilian-University, Munich, Germany.

Background: PAPA syndrome is a recently identified hereditary autoinflammatory syndrome clinically characterized by pyogenic arthritis, severe acne, and pyoderma gangrenosum. It is caused by mutations in the PSTPIP1 gene and may be closely linked to the aseptic abscesses syndrome, which has been shown to be associated with CCTG repeat amplification in the promoter region of PSTPIP1.

Objective: We describe two unrelated patients with a clinical presentation quite similar to, yet distinct from, PAPA syndrome. Read More

View Article
March 2012

Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.

Dermatol Online J 2017 Dec 15;23(12). Epub 2017 Dec 15.

Division of Dermatology, Department of Medicine, University of Stellenbosch and Tygerberg Academic Hospital, Tygerberg, Cape Town, South Africa.

PASH syndrome (pyoderma gangrenosum, acne, and suppurative hidradenitis) forms part of the spectrum of autoinflammatory diseases. We report an unusual case of PASH syndrome in a patient with end-stagerenal disease (ESRD) who was successfully treated with the tumor necrosis factor inhibitor, adalimumab. The case underscores the challenges associatedwith the treatment of PASH syndrome as well as the ongoing search to establish a genetic basis for the syndrome. Read More

View Article
December 2017

Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.

Authors:
P D Shenefelt

Cutis 1996 May;57(5):315-9

Department of Internal Medicine, College of Medicine, University of South Florida, Tampa 33612, USA.

Pyoderma gangrenosum often presents a difficult therapeutic challenge. The case is described of a 42-year-old black man with the association of cystic acne, hidradenitis suppurativa, and seronegative arthritis with pyoderma gangrenosum. The pyoderma gangrenosum ulcers remained refractory to treatment until therapies aimed in part at the associated diseases were begun. Read More

View Article
May 1996